葛兰素史克Glaxosmithkline plc (GSK) 2019年年度报告「LSE」.pdf

1、Annual Report 2019ContentsStrategic reportOur business model 01Chairmans statement 03CEOs statement 04Financial performance 06Our long-term priorities 09Our culture 10Key performance indicators 11Industry trends 12Stakeholder engagement 15Pharmaceuticals 17Vaccines 23Consumer Healthcare 27Trust 30Ri

2、sk management 43Group financial review 49Corporate GovernanceChairmans Governance statement 76Our Board 78Our Corporate Executive Team 82Responsible leadership 84Division of responsibilities 90Composition,succession and evaluation 92Nominations Committee report 92Audit,risk and internal control 96Au

3、dit&Risk Committee report 96Science Committee report 107Corporate Responsibility Committee report 109Section 172 statement 111Directors report 113Remuneration reportChairmans annual statement 116Annual report on remuneration 1192020 Remuneration policy summary 1402020 Remuneration policy report 141F

4、inancial statementsDirectors statement of responsibilities 152Independent Auditors report 154Financial statements 166Notes to the financial statements 170Financial statements of GlaxoSmithKline plc prepared under UK GAAP 252Investor informationQuarterly trend 258Five-year record 263Product developme

5、nt pipeline 269Products,competition and intellectual property 272Principal risks and uncertainties 275Share capital and share price 288Dividends 290Financial calendar 291Annual General Meeting 2020 291Tax information for shareholders 292Shareholder services and contacts 294US law and regulation 296G

6、roup companies 299Glossary of terms 311Cautionary statementSee the inside back cover of this document for the cautionary statement regarding forward-looking statements.Non-IFRS measuresWe use a number of adjusted,non-IFRS,measures to report the performance of our business.Total reported results repr